An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition

about

Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects.Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.

P2860

Q40604466-9D3A5880-153D-4F40-AD9F-E0816288EACF Q53631003-F9E956A8-8980-439F-B874-155976FBEAA3

P2860

An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition

Item

http://www.wikidata.org/entity/Q41914881

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

An open-label, randomized, cro ...... 10 mg under fasting condition

@en

type

Item

label

An open-label, randomized, cro ...... 10 mg under fasting condition

@en

prefLabel

An open-label, randomized, cro ...... 10 mg under fasting condition

@en

P1476

An open-label, randomized, cro ...... 10 mg under fasting condition

@en

P2093

Bhupesh Dewan

http://www.w3.org/2001/XMLSchema#string

Raghuram Chimata

http://www.w3.org/2001/XMLSchema#string

P2860

Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons

Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future.

Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.

Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.

Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?

A prospective randomized trial of lafutidine vs rabeprazole on post-ESD gastric ulcers.

Neural emergency system in the stomach.

Gastroprotective mechanism of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonistic activity.

The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.

Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.

P304

112-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4292/WJGPT.V1.I5.112

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51131619

http://www.w3.org/2001/XMLSchema#string

P698

21577305

http://www.w3.org/2001/XMLSchema#string

P932

3091155

http://www.w3.org/2001/XMLSchema#string

An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition

about

P2860

P2860

An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932